| Identification | Back Directory | [Name]
(8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[(3-(formylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-5,12-naphthacenedione | [CAS]
63084-42-4 | [Synonyms]
Baumycin C1 N-Formyldaunorubicin (8S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10α-[[3-formylamino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[(3-(formylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-5,12-naphthacenedione 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)- | [Molecular Formula]
C28H29NO11 | [MOL File]
63084-42-4.mol | [Molecular Weight]
555.53 |
| Hazard Information | Back Directory | [Uses]
Baumycin C1 is a molecule of interest in the research of Doxorubicin (23214-92-8) analogs/impurities. Doxorubicin is a chemotherapy drug commonly used to treat leukemias and Hodgkin''s lymphoma, cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma, among others. |
|
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|